Wegovy vs Mounjaro: The Science Behind Different Doses
Why Wegovy Dose Appears Lower Than Mounjaro in Weight Management
Understanding why Wegovy dose appears lower than Mounjaro requires examining their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that reaches its maximum therapeutic effect at 2.4mg weekly. Mounjaro uses tirzepatide, which targets both GLP-1 and GIP receptors, requiring higher doses up to 15mg to achieve dual-pathway activation. These aren't directly comparable because they work through different biological pathways to support weight management alongside a reduced-calorie diet and increased physical activity.
The dosing schedules also reflect each medication's pharmacokinetic profile and clinical trial optimisation. Wegovy's proven efficacy in the STEP trials demonstrated significant weight management benefits at 2.4mg, with the recently approved 7.2mg dose offering an additional option for certain patients. Mounjaro's dosing reflects its dual-receptor mechanism, where higher quantities are needed to effectively engage both GIP and GLP-1 pathways simultaneously for appetite regulation and metabolic support.
Prescription Weight Loss Treatment Pricing and Value Comparison
At EverydayMeds, Wegovy prescription weight loss treatment starts at £79.99 for the 0.25mg starter dose, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose at £209.99. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive prices. Our Getting Started bundles, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, provide convenient multi-week supplies.
When considering why Wegovy dose requirements differ from Mounjaro, the cost-effectiveness becomes clearer through lower per-dose pricing and fewer injection volume requirements. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, offering treatment continuity without repeated ordering. Both treatments require similar dose escalation periods, but Wegovy's lower absolute dose means smaller injection volumes and potentially improved injection comfort throughout your weight management programme.
Clinical Evidence Behind Wegovy Dose Selection for Weight Management
The STEP clinical trial programme established why Wegovy dose levels were optimised at 2.4mg for most patients. In STEP 1, participants taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 demonstrated sustained 15.2% weight reduction at two years, confirming long-term efficacy at this dose level.
Recent SELECT trial data showed that Wegovy may provide additional cardiovascular benefits, with a 20% reduction in major cardiovascular events. These outcomes were achieved at the standard 2.4mg maintenance dose, demonstrating that effective weight management doesn't require the higher absolute doses seen with dual-receptor medications like Mounjaro.
How Wegovy Works at Lower Doses Than Mounjaro
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. This targeted approach explains why Wegovy dose requirements remain lower than Mounjaro's dual-pathway system. The medication works on brain appetite centres to may reduce food cravings whilst slowing gastric emptying, helping you feel satisfied with reduced calorie intake. Unlike medications requiring dual-receptor activation, Wegovy's single-pathway mechanism achieves therapeutic effects at lower absolute doses. The 2.4mg maintenance dose provides optimal GLP-1 receptor engagement for sustained weight management when used alongside lifestyle modifications. This precision targeting explains the dosing differences between these prescription-only medicines for weight management.
Simple Ordering Process for Wegovy Weight Loss Treatment
Starting your Wegovy prescription weight loss journey involves a straightforward 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (or 24 hours with express service), ensuring safe and appropriate prescribing of this prescription-only medicine. Once approved, your Wegovy pens arrive via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transport. The GPhC-registered pharmacy service (#9012878) ensures pharmaceutical quality and regulatory compliance. Your prescriber will explain why Wegovy dose escalation follows a specific schedule and provide ongoing support throughout your treatment programme.
Storage and Practical Advantages of Wegovy's Lower Dose Design
Wegovy's lower dose design offers practical storage advantages, with each pen remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration—significantly longer than Mounjaro's 21-day room temperature limit. The FlexTouch pen system delivers precise doses with minimal injection volume, making weekly administrations more comfortable throughout the escalation schedule. Dose progression follows a mandatory schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This gradual escalation helps minimise potential side effects whilst optimising therapeutic benefits. The lower absolute dose means smaller pen sizes and reduced storage requirements compared to higher-dose weight management treatments.
Understanding Dose Efficiency in Modern Weight Management Prescriptions
The question of why Wegovy dose appears lower than Mounjaro highlights advances in pharmaceutical precision targeting. Modern weight management medicines achieve efficacy through specific receptor engagement rather than absolute dose quantities. Wegovy's semaglutide formulation demonstrates how targeted GLP-1 activation can deliver significant weight management benefits without requiring dual-pathway doses.
This efficiency translates to practical benefits including reduced injection volumes, longer storage stability, and streamlined dose escalation schedules. Both treatments remain available through EverydayMeds, with your prescriber able to explain individual suitability based on your medical history and weight management objectives. The dosing differences reflect scientific optimisation rather than treatment superiority, ensuring patients receive appropriate pharmaceutical support for their weight management goals.
Start Your Prescription Weight Loss Journey with Expert Guidance
Begin your Wegovy treatment today with our comprehensive clinical assessment and expert prescriber support. New customers can use discount code FIRST40 at checkout, whilst returning patients apply DOSE25 for continued savings on their prescription weight loss medication. Our Getting Started bundles provide convenient multi-week supplies, ensuring treatment continuity throughout your dose escalation period. Understanding why Wegovy dose differs from other treatments becomes clearer with professional prescriber guidance tailored to your individual circumstances. Visit our Wegovy collection at https://everydaymeds.co.uk/collections/wegovy to begin your clinically-supported weight management programme with this proven prescription-only medicine.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
